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SUMMARY
An abnormal chromosome number, aneuploidy, is a common characteristic of tumor cells. Boveri
proposed nearly 100 years ago that aneuploidy causes tumorigenesis, but this has remained
untested due to the difficulty of selectively generating aneuploidy. Cells andmice with reduced levels
of the mitosis-specific, centromere-linked motor protein CENP-E are now shown to develop aneu-
ploidy and chromosomal instability in vitro and in vivo. An increased rate of aneuploidy does drive
an elevated level of spontaneous lymphomas and lung tumors in aged animals. Remarkably, how-
ever, in examples of chemically or genetically induced tumor formation, an increased rate of aneu-
ploidy is a more effective inhibitor than initiator of tumorigenesis. These findings reveal a role of
aneuploidy and chromosomal instability in preventing tumorigenesis.INTRODUCTION
It was well known a century ago that aneuploidy is a com-
mon characteristic of cancer cells. Based on this cor-
relation, and his observations of the pathological conse-
quences of aneuploidy in fertilized sea urchin oocytes,
Theodor Boveri proposed in 1902 and 1914 that aneu-
ploidy drives tumorigenesis (Boveri, 1902, 1914). With
the subsequent discovery of oncogenes and tumor sup-
pressors, Boveri’s hypothesis, now known as the aneu-
ploidy hypothesis, has remained controversial. Aneu-
ploidy-inducing carcinogens do drive tumorigenesis, but
these have subsequently been shown to be mutagenic
as well (Li et al., 1997; Quintanilla et al., 1986). On the other
hand, human cells have been reported to become trans-
formed without widespread genetic changes, includinganeuploidy, due to coexpression of the SV40 large T anti-
gen, the telomerase catalytic subunit hTERT, and
oncogenic ras (Hahn et al., 1999; Zimonjic et al., 2001).
However, later examination proved 70% of these cells to
have a nondiploid karyotype (Li et al., 2000).
Aneuploidy caused by reduction in one of three essen-
tial components of the mitotic checkpoint, Mad2 (Babu
et al., 2003; Baker et al., 2004; Michel et al., 2001), Bub3
(Babu et al., 2003; Baker et al., 2004; Michel et al.,
2001), or BubR1 (Babu et al., 2003; Baker et al., 2004;
Michel et al., 2001), has been implicated in tumorigenesis.
The mitotic checkpoint, also known as the spindle assem-
bly checkpoint, is a major mitotic cell-cycle control mech-
anism that prevents missegregation of even single
chromosomes by delaying advance to anaphase until
the centromeres of all chromosomes have attached toSIGNIFICANCE
Aneuploidy is a remarkably common feature of human cancers and has been proposed to drive tumorigenesis, to
contribute to tumor progression, or to be completely benign. Aneuploidy due to continuousmissegregation of ran-
dom, individual chromosomes is now shown to promote spontaneous tumorigenesis in aged animals, but only at
a modest frequency. Strikingly, however, aneuploidy and chromosomal instability due to reduction in the mitosis-
specific motor CENP-E actually inhibits tumorigenesis in the presence of additional genetic damage. These data
advance a paradigm in which low levels of chromosomal instability promote tumor initiation and progression, but
higher levels are protective and suggest that highly aneuploid, chromosomally unstable tumors may exhibit
enhanced sensitivity to aneugenic or DNA-damaging drugs.Cancer Cell 11, 25–36, January 2007 ª2007 Elsevier Inc. 25
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Aneuploidy Both Promotes and Inhibits Tumorsspindle microtubules (Cleveland et al., 2003). Mice hetero-
zygous for the essential mitotic checkpoint protein Mad2
develop spontaneous, benign, self-limiting lung adeno-
mas with long latencies (18–20 months; Michel et al.,
2001).Bub3+/mice do not show an increase in spontane-
ous tumorigenesis but do exhibit a trend toward increased
sensitivity to chemically induced lung tumors (Babu et al.,
2003; Baker et al., 2006; Kalitsis et al., 2005), while mice
with reduced levels of BubR1 exhibit increased suscepti-
bility to tumors induced by carcinogens (Baker et al., 2006;
Dai et al., 2004) or mutations in the adenomatous poly-
posis coli tumor suppressor (Rao et al., 2005). Moreover,
germline mutations in the gene encoding BubR1 have
recently been identified in patients with the inherited
cancer-prone syndrome mosaic variegated aneuploidy
(Hanks et al., 2004; Matsuura et al., 2006).
Nevertheless, no conclusion can be drawn from these
apparent correlations between diminished mitotic check-
point signaling and tumorigenesis, since each of these
mitotic checkpoint contributors is also present throughout
interphase and is known to participate in cellular functions
other than chromosome segregation. Mad2, for example,
is bound to the nuclear envelope and nuclear pores
(Campbell et al., 2001; Iouk et al., 2002) and has been
implicated both in the DNA replication checkpoint (Sugi-
moto et al., 2004) and in promoting gross chromosomal
rearrangements in yeast (Myung et al., 2004). Bub3 inter-
acts with histone deacetylases, acts to repress transcrip-
tion (Yoon et al., 2004), and contributes to chromosomal
rearrangements (Myung et al., 2004). BubR1 has been
shown to be involved in numerous cellular processes in-
cluding premature aging (Baker et al., 2004), apoptosis
(Baek et al., 2005; Kim et al., 2005; Shin et al., 2003),
fertility (Baker et al., 2004), megakaryopoiesis (Wang et al.,
2004), gross chromosomal rearrangements (Myung
et al., 2004), and the response to DNA damage (Fang
et al., 2006). Thus, the ability of aneuploidy per se to drive
tumorigenesis remains untested by efforts with reduced
levels of any of these multifunctional proteins. Rather,
the hypothesis that aneuploidy promotes tumorigenesis
remains unproven, as are alternative views that aneu-
ploidy is merely a benign side effect of transformation or
a contributor to tumor progression but not to tumor initia-
tion (Marx, 2002).
We report here that cells and animals with reduced
levels of CENtromere-associated Protein-E (CENP-E)
become aneuploid due to the random missegregation of
one or a few chromosomes at high rates in the absence
of DNA damage. CENP-E is an essential, mitosis-specific,
cell-cycle-regulated motor that accumulates primarily in
late G2 and is used in mitosis and then degraded at the
end of mitosis as quantitatively as is cyclin B (Brown
et al., 1994). A large (312 kDa in human) kinesin-like
motor protein, CENP-E is conserved in all but the simplest
metazoans and plays at least two critical functions during
mitosis (Putkey et al., 2002; Wood et al., 1997; Yen et al.,
1991; Yucel et al., 2000). First, it participates in making
and/or maintaining the interactions between chromo-
somes and the microtubules of the mitotic spindle26 Cancer Cell 11, 25–36, January 2007 ª2007 Elsevier Inc.(McEwen et al., 2001; Putkey et al., 2002). Second,
CENP-E serves a bifunctional role in the mitotic check-
point. It first stimulates mitotic checkpoint signaling by
serving as a ‘‘cyclin-like’’ activator of BubR1 kinase activ-
ity (Mao et al., 2003; Weaver et al., 2003) and then turns off
production of the BubR1-dependent ‘‘wait anaphase’’
inhibitor when all chromosomes have made appropriate
attachments to spindle microtubules (Mao et al., 2005).
We have exploited the property that cells and mice with
reduced CENP-E generate high rates of aneuploidy in the
absence of other observable defects to test the hypothe-
ses that aneuploidy (1) drives tumorigenesis, (2) is benign,
or (3) promotes tumor progression but not initiation. We
find that aneuploidy due to the repetitive missegregation
of one or a few whole chromosomes contributes to trans-
formation in vitro and causes a modest increase in spon-
taneous spleen and lung tumors in vivo. Surprisingly, in
examples of chemically or genetically induced tumor
formation, an increased rate of aneuploidy can be a
more effective inhibitor than initiator of tumorigenesis.
RESULTS
CENP-E+/Cells Rapidly Develop Aneuploidy In Vitro
Primary mouse embryo fibroblasts (MEFs) were pre-
pared from mice containing one normal and one dis-
rupted CENP-E allele. Immunoblotting for CENP-E
revealed that CENP-E+/ cells contained the expected
50% of the CENP-E level present in comparable wild-
type cells (Figure 1A; Figures S1A and S1B in the Supple-
mental Data available with this article online), and this
reduced level remained associated with kinetochores
(Figure 1B, upper panel). As expected, CENP-E protein
was undetectable in interphase cells (Figure 1B, lower
panel). Reduction in CENP-E produced cells in which
one or a few chromosomes were unable to make stable at-
tachments to microtubules and remained misaligned near
one of the spindle poles (Figure 1C, lower panel). These
misaligned chromosomes subsequently become misse-
gregated in one-quarter of CENP-E/ cells (Weaver
et al., 2003). As an initial measure of the fidelity of chromo-
some transmission in CENP-E+/ fibroblasts, chromo-
some spreads (also known as metaphase spreads) were
prepared from cells arrested in mitosis by drug-induced
microtubule disassembly (Figure 1D). The number of chro-
mosomes per spread was determined, and cells were
scored as diploid (2n = 40), tetraploid (4n = 80), or aneu-
ploid. Although aneuploidy increased with time in culture
for both genotypes, primary MEFs with reduced CENP-E
were significantly more aneuploid than wild-type MEFs at
all time points (Figure 1E).
Examination of the absolute number of chromosomes
per cell revealed two populations in each genotype (n =
100 spreads from each of three independent experiments).
While most of the cells were diploid or near-diploid, a sub-
set of the population (2%–20%, increasing with time in
culture) contained a tetraploid or near-tetraploid number
of chromosomes, consistent with failure of cytokinesis in
a prior mitosis. The percentage of cells that failed
Cancer Cell
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(A) Immunoblot showing that CENP-E protein levels are reduced byR50% in CENP-E+/ primary MEFs as compared to CENP-E+/+ MEFs.
(B) CENP-E (green) localizes to kinetochores (which assemble at the centromeric regions of mitotic chromosomes) during mitosis. CENP-E is
undetectable during interphase. Tubulin, red; DNA, blue.
(C) Upper panel; normal metaphase alignment of chromosomes in a wild-type cell. Lower panel; CENP-E+/ cell containing a misaligned chromosome
near the spindle pole (arrow). DNA, blue; tubulin, red.
(D) Representative chromosome (metaphase) spread prepared from a primary MEF. DNA was visualized with DAPI. Replicated chromosomes (sister
chromatids) appear as V shapes because the centromeres are very close to the telomeres (acrocentric). Diploid murine cells contain 40 replicated
chromosomes when arrested in mitosis, as these are.
(E) CENP-E+/ cells are significantly more aneuploid than wild-type cells. The percentage of aneuploid cells in primary MEFs grown in culture for 3–19
days is graphed as mean ± SD. Aneuploidy increases with time in culture in both genotypes, but CENP-E+/ cells are significantly more aneuploid at all
time points. n = 100 spreads from each of three independent experiments. *p < 0.05.
(F and G) Absolute chromosome numbers of primary MEFs grown in culture for 6 (F) or 12 (G) days, showing the presence of both diploid (or near-
diploid) and tetraploid (or near-tetraploid) populations. The insets show an enlarged view of the near-tetraploid populations. n = 100 spreads from
each of three independent experiments.
(H) Immunoblot showing histone H2AX is phosphorylated (a marker of DNA damage) at similar levels in wild-type and CENP-E+/ cells. DNA damage
was induced by 6.5 hr treatment with 0.5 mM doxorubicin. Coomassie is shown as a loading control.
(I) Spectral karyotyping of a CENP-E+/ primary cell showing numerical but not structural aberrations. Fifteen cells from two independent animals
were examined.
(J) Population growth rates of CENP-E+/+ and CENP-E+/ cells are indistinguishable. Data are graphed as mean ± SEM.
(K) Colony-forming assay. Individual CENP-E+/ cells are significantly less viable than CENP-E+/+ cells. Data are presented as mean ± SEM. *p < 0.05.cytokinesis was identical in cells with normal and reduced
levels of CENP-E. However, in both populations, the range
of chromosome numbers in CENP-E+/ cells was wider
than the range of chromosome numbers found in wild-
type cells, consistent with missegregation of one or a few
chromosomes per division (Figures 1F and 1G).
CENP-E accumulates in late G2, localizes to kineto-
chores (which assemble at the centromeric region ofmitotic chromosomes) during all phases of mitotic chro-
mosome movement, and is degraded during mitotic exit
(Brown et al., 1994). Even at peak levels, CENP-E accu-
mulates only to levels sufficient to provide 50 molecules
per kinetochore (Brown et al., 1994). It is undetectable in
nondividing tissues (Figure S1C) and throughout most of
interphase in cycling cells (Figure 1B, lower panel). Be-
yond its kinesin-like motor domain, it has no catalyticCancer Cell 11, 25–36, January 2007 ª2007 Elsevier Inc. 27
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vide a significant role when present at trace amounts.
CENP-E is therefore highly unlikely to participate in cellular
functions other than those in mitosis. Consistent with this,
DNA damage, as assessed by levels of phosphorylated
histone H2AX, is not elevated in untreated CENP-E+/
cells (Figure 1H, left lanes). However, DNA damage
caused by treatment with the DNA topoisomerase II inhib-
itor doxorubicin induced phosphorylation of H2AX to
a similar extent in both wild-type and CENP-E+/ MEFs,
indicating that the DNA damage response remains intact
in cells with reduced CENP-E (Figure 1H, right lanes).
Sequencing of the p53 gene in CENP-E+/ cells revealed
no mutations, as expected. Furthermore, spectral karyo-
typing (SKY) revealed that chromosomes in CENP-E+/
cells do not exhibit structural rearrangements, including
translocations, insertions, and deletions [Figure 1I, karyo-
type 38XX, (8);(X)]. Therefore, although a role for
CENP-E outside of mitosis cannot be formally excluded,
no evidence supports such a hypothetical role, and there
is substantial evidence against one. We conclude that
CENP-E heterozygosity induces near-diploid aneuploidy
and chromosomal instability in the absence of other
observable defects.
Aneuploidy Contributes to Transformation In Vitro
The ability of aneuploidy to contribute to tumorigenicity
was examined in primary MEFs, as well as in immortalized
MEFs prepared in two different ways. First, we exploited
the property that MEFs that are homozygous null for the
tumor suppressor p19/ARF are immortal under standard
culture conditions, since p19/ARF is essential for cellular
senescence in mouse cells (Kamijo et al., 1997). MEFs
that were null for p19/ARF and heterozygous for CENP-
E were generated from embryos of the corresponding
genotypes, after two rounds of mating of mice containing
disrupted p19/ARF and/or CENP-E alleles. Second,
immortalized MEFs were prepared by transfecting CENP-
E+/+ or CENP-E+/ primary MEFs with the SV40 large T
antigen, one of three cooperating transforming antigens
in the SV40 genome. It should be noted that, although
SV40 large T can transform some immortalized cell lines
autonomously, it is incapable of independently transform-
ing primary MEFs (Rundell and Parakati, 2001). Interest-
ingly, immortalization of MEFs by SV40 large T is accom-
panied by conversion to tetraploidy (data not shown).
Examination of the in vitro characteristics of chromoso-
mally unstable CENP-E+/ cells relative to their normal
counterparts revealed no differences in the growth rate
(Figure 1J). Similarly, in p19/ARF null cells or those immor-
talized with SV40 large T antigen, growth rates were indis-
tinguishable between cells generating higher rates of
aneuploidy from reduction of CENP-E and those with nor-
mal CENP-E content (Figure S2A). Since homozygous
loss of individual autosomes would be expected to gener-
ate a proportion of nonviable progeny, the unchanged
doubling times indicate that rates of chromosome loss
are too modest to generate a high proportion of such lethal
losses in the overall cell population. However, assessment28 Cancer Cell 11, 25–36, January 2007 ª2007 Elsevier Inc.of colony growth from single cells revealed a clear differ-
ence in the proportion of surviving colonies, with viability
of CENP-E+/ cells of all three cell types clearly reduced
compared to CENP-E+/+ cells (Figure 1K; Figure S2B).
Aneuploid CENP-E+/ cells were also tested for charac-
teristics of transformed cell growth. Primary MEFs, as well
as MEFs immortalized from homozygous loss of p19/ARF
or transfection of the SV40 large T antigen, were analyzed
for the ability to form foci on plastic. Staining of confluent
cells with crystal violet revealed that, in all three cell types,
aneuploidy due to CENP-E heterozygosity strongly en-
hanced the ability to form foci (Figures 2A and 2B), some
of which grew large enough to be visible to the naked
eye (Figure S3A). Immunofluorescence staining revealed
these foci to be densely packed three-dimensional
masses of cells containing normal, abnormal, dying, and
dividing cells (Movie S1). Immortalized CENP-E+/ cells
that did not form foci grew to higher saturation densities
than corresponding CENP-E+/+ cells (Figures S3C–S3D).
The influence of aneuploidy on anchorage-independent
growth in soft agar was also examined. Neither primary
CENP-E+/ nor CENP-E+/+ MEFs grew in soft agar, irre-
spective of passage number (Figure 2C, upper panels).
A similar situation was observed for early-passage p19/
ARF null cells (Kamijo et al., 1999, and data not shown).
Late-passage (R30 passages) p19/ARF null, CENP-E+/+
MEFs did exhibit limited growth in soft agar, but CENP-E
heterozygosity eliminated this in cells derived from most
p19/ARF null embryos (Figure 2C, center panels). How-
ever, in a minority of p19/ARF null cells, CENP-E heterozy-
gosity greatly facilitated growth in soft agar (Figure 2C,
center panels, inset), presumably as a consequence of
increased random chromosome missegregation produc-
ing a rare aneuploid genotype that cooperates with loss
of p19/ARF to transform cells. Similarly, in cells express-
ing SV40 large T, CENP-E heterozygosity reduced the
number of microscopic colonies formed in soft agar rela-
tive to CENP-E+/+ cells (Figure S3E), while the very small
number of macroscopic colonies (with high growth rates)
increased significantly in cells with reduced CENP-E (Fig-
ure S3F). These latter colonies grew substantially larger
and much more rapidly than similar colonies of CENP-
E+/+ cells (Figure 2C, lower panels).
Aneuploidy Contributes to Tumorigenicity In Vivo
To test if increased chromosomal loss or gain would affect
tumorigenicity, primary MEFs, p19/ARF null MEFs, and
SV40 large T immortalized MEFs that had normal or re-
duced CENP-E levels (and that had not been passaged
through soft agar) were tested for the ability to form
tumors when injected into nude mice. Animals injected
with primary MEFs and low-passage immortalized MEFs
did not form tumors at the injection site. Nor did animals
injected with late-passage p19/ARF cells with normal
levels of CENP-E, even 3 months after injection (n = 6).
The majority of p19/ARF null, CENP-E+/ cells also did
not form tumors in nude mice (n = 6). However, 19 of 19
mice injected with transformed p19/ARF null, CENP-E+/
cells (as scored by the ability to grow in soft agar) formed
Cancer Cell
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hibit Characteristics of Transformed Cell
Growth
(A) Schematic of the experiment.
(B) CENP-E heterozygosity results in focus
formation on plastic in (top) primary MEFs,
(middle) MEFs immortalized due to homozy-
gous loss of p19/ARF, and (bottom) MEFs im-
mortalized due to transfection with SV40 large
T antigen. Foci appear as puncta of enriched
dye staining (arrows) and are indicative of
loss of contact inhibition.
(C) CENP-E heterozygosity facilitates growth in
soft agar in (bottom) SV40 large T-expressing
cells and (middle, inset: shown at one-fourth
the magnification of the main panels) in a sub-
set of p19/ARF/ cells. However, (middle) in a
majority of p19/ARF null cells, CENP-E hetero-
zygosity abrogates the limited growth in soft
agar observed in late-passage p19/ARF/
MEFs. (Top) Primary CENP-E heterozygous
and CENP-E wild-type fibroblasts did not
form colonies. Late-passage cells (>passage
30) were plated in soft agar and monitored for
anchorage-independent growth. Early-pas-
sage cells did not give rise to colonies in soft
agar (data not shown). White arrows indicate
single cells that did not grow. Black arrows in-
dicate colonies.tumors at the injection site with a very short latency (1–2
weeks; Figure 3A). Ten of ten mice injected with high-pas-
sage (pR 45) CENP-E+/ MEFs expressing SV40 large T
formed tumors at the injection site with a latency between
1 and 6 weeks. None of the mice injected with CENP-E+/+
MEFs immortalized with SV40 large T formed tumors at
the injection site within the same time frame (Figure 3B).
(One of 12 mice injected with late-passage CENP-E+/+
cells expressing SV40 large T did form a tumor at the injec-
tion site, but it took 12 weeks to form, twice the length of
the longest latency of tumors formed by CENP-E+/ cells
expressing SV40 large T.)
Histological examinationof the tumors fromp19/ARF/,
CENP-E+/, or CENP-E+/ cells expressing SV40 large T
revealed each to be a fibromyosarcoma, as expected for
derivation from the injected MEFs. This conclusion was
confirmed by genotyping, which showed the continued
presence of one wild-type and one null allele (Figure S4;
data not shown). Cell lines were successfully isolated
from a subset of the tumors, and chromosome spreads
from these lines were examined (Figures 3C and 3D). The
tumor cells exhibited a wide range of chromosome num-
bers, indicative of the expected chromosomal instability.
Age-Dependent Increases in Aneuploidy in Animals
with Reduced CENP-E
Aneuploidy rates were assessed in three different tissue
types from mice with normal or reduced levels of CENP-
E. Chromosome spreads from peripheral blood lympho-cytes collected from mice from 2 to 20 months of age
were evaluated. Age-dependent accumulation of aneu-
ploidy in lymphocytes was observed in both genotypes,
but at all ages CENP-E+/ animals contained a significantly
higher percentage of aneuploid cells. Notably, a majority of
CENP-E+/ lymphocytes were aneuploid by 10 months of
age (Figure 4A).
Similarly, analysis of chromosome spreads from sple-
nocytes of 8-month-old animals revealed 35% of spleno-
cytes from CENP-E+/ animals to have a nondiploid
number of chromosomes, as compared to 10% of spleno-
cytes from age-matched CENP-E+/+ littermates (Fig-
ure 4B). The distribution of chromosomes per cell was
not symmetrically centered on 40 but was skewed
toward chromosome loss. Chromosome numbers of
25–39 were common, while chromosome numbers above
40 were only rarely observed. More than 42 chromosomes
were not detected in mice under 12 months of age (Fig-
ures 4C–4F). No tetraploid cells were detected in spleno-
cytes or in lymphocytes from peripheral blood (Figure 4;
data not shown), unlike in the MEFs grown in vitro. This
skewing toward chromosome loss was consistently
observed in every sample of splenocytes and peripheral
blood lymphocytes (Figures 4C–4F; data not shown) and
is consistent with previous observations in normal devel-
oping neuronal precursors (Kaushal et al., 2003; McCon-
nell et al., 2004; Rehen et al., 2001; Yang et al., 2003).
Finally, aneuploidy in colon sections was determined
using interphase fluorescence in situ hybridizationCancer Cell 11, 25–36, January 2007 ª2007 Elsevier Inc. 29
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Aneuploidy Both Promotes and Inhibits TumorsFigure 3. Aneuploidy Due to CENP-E Heterozygosity Contributes to Tumorigenicity
Cells that had not been passaged through soft agar were injected into nude mice.
(A) Nude mice injected with late-passage p19/ARF/, CENP-E+/ cells that grow in soft agar form tumors at the injection site (arrows), while mice
injected with late-passage p19/ARF/, CENP-E+/ cells that abrogate growth in soft agar or late-passage p19/ARF/, CENP-E+/+ cells do not form
tumors.
(B) Nude mice injected with CENP-E+/ cells expressing SV40 large T form tumors at the injection site (arrows), but mice injected with CENP-E+/+ cells
expressing SV40 large T do not.
(C and D) Chromosome spreads prepared from p19/ARF/, CENP-E+/ tumor cells (C) (n = 30) and CENP-E+/ SV40 large T-expressing tumor cells
(D) (n = 100). The number of chromosomes in the spread shown is noted in the bottom right-hand corner.(FISH). Sections from 19-month-old animals were hybrid-
ized with FISH probes against chromosome 2 or the Y
chromosome. In both cases, colon cells from CENP-E+/
mice were significantly more aneuploid (4- to 6-fold)
than colon cells from age-matched wild-type animals
(Figures 5A and 5B), reaching 17%–20% of total cells for
each of the chromosomes examined.
Despite elevated levels of aneuploidy in all cell types
examined, CENP-E+/ animals were overtly normal. Both
male and female animals were viable and fertile and pro-
duced normal litter sizes (6.2 ± 2.5 mice per litter; n = 20
litters). At all ages, CENP-E+/ animals maintained healthy
body weights (Figure S5A), and weights of individual or-
gans were not significantly different from their wild-type
littermates (Figures S5B–S5D).
Aneuploidy Drives Tumorigenesis In Vivo
To determine if the elevated aneuploidy generated in vivo
in mice with reduced CENP-E can drive tumorigenesis,
cohorts of wild-type and CENP-E+/ animals were aged
to 19–21 months and examined for the development of
spontaneous tumors. Lymphomas of the spleen were
detected in 10% of CENP-E+/ mice, while none of the
wild-type mice had similar tumors, a difference that was30 Cancer Cell 11, 25–36, January 2007 ª2007 Elsevier Inc.statistically significant (p = 0.0402; Figure 6A). Lymphomas
exhibited effacement of lymphoid follicles and replace-
ment of splenic architecture with a monoclonal prolifera-
tion of neoplastic cells (Figure 6C; Figures S6C–S6F). Ma-
lignant cells displayed an elevated nucleus to cytoplasm
ratio and contained large nuclei (4- to 6-fold larger than
normal lymphocytes) with prominent nucleoli (Figure 6E).
Additionally, a statistically significant 3-fold increase in
lung tumors in the aged CENP-E+/ versus normal litter-
mates was observed (p = 0.0492; Figure 6A). Histological
examination identified these as pulmonary adenomas
(Figures 6G–6I). Thus, aneuploidy caused by elevated
rates of whole-chromosome missegregation in CENP-E+/
animals validates Boveri’s initial hypothesis: aneuploidy
can indeed promote tumorigenesis in the absence of other
observable defects.
Aneuploidy Inhibits Tumorigenesis in Tissues Prone
to Tumor Formation
Liver tumors were the most common neoplasms observed
in our wild-type mice, with 14% of wild-type animals
having one or more. Despite increases in lung adenomas
and splenic lymphomas, widespread aneuploidy was ac-
companied by a 50% decrease of spontaneous liver
Cancer Cell
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cytes and Splenocytes from Reduced
CENP-E
(A) CENP-E+/ mice contain high levels of
aneuploid cells that are not eliminated from
the cycling population. Aneuploidy, scored by
preparing chromosome spreads from periph-
eral blood cells (n = 50 from each of two inde-
pendent experiments), increases with age.
Data are shown as the mean ± SD.
(B) Spleen cells from CENP-E+/ animals have
elevated levels of aneuploidy (as scored by
chromosome spreads). Data are shown as
the mean ± SD.
(C–F) The number of chromosomes per cell in
splenocytes from 8-month-old animals (C) or
peripheral blood lymphocytes from animals 3
months (D), 10 months (E), and 20 months (F)
of age is shown. No spreads containing fewer
than 24 or more than 57 chromosomes were
counted.tumors in aged CENP-E+/ animals (to 7%; Figure 7A;
Table S1). None of these animals had more than one.
Additionally, the tumors in the wild-type livers were signif-
icantly larger than the tumors observed in the CENP-E+/
animals (Figure 7B). Although the increase in the number
of liver tumors identified in wild-type animals versus
CENP-E+/ animals did not quite reach statistical signifi-
cance (p = 0.0578), the size of the tumors observed in
wild-type animals versus those in CENP-E+/ animals
was significantly different (p = 0.0037). Interestingly, in
addition to the polyploidy commonly identified in hepato-
cytes, 20% of wild-type murine liver cells missegregate
one or more chromosomes at each mitosis (Putkey et al.,
2002). Thus, increasing aneuploidy further by reduction
in CENP-E actually inhibits the growth of spontaneous
tumors in the liver.
To determine whether aneuploidy due to recurrent
losses or gains of one or a few chromosomes affected
tumor initiation or progression in tumors provoked by
exposure to a well-characterized carcinogen, 7,12-dime-
thylbenz[a]anthracene (DMBA), thirty-eight animals were
given a single dose of DMBA at postnatal day 3–5. The an-
imals were sacrificed at 8 months of age and examined for
tumors. Forty percent of the wild-type animals harbored
a single lung tumor. An additional wild-type animal that
did not develop a lung tumor contained one ovarian andtwo mammary tumors. Surprisingly, lung tumors were
identified in a smaller portion of the CENP-E+/ animals
(31%; Figure 7C), and these tumors also showed a trend
toward reduced size (0.30 ± 0.06 mm3 in wild-type versus
0.20 ± 0.11 mm3 in CENP-E+/). No tumors were identified
in any other organs in the CENP-E+/ mice. The apparent
reduction in tumorigenesis observed in CENP-E+/
animals after DMBA treatment did not reach statistical
significance (p = 0.1255). However, aneuploidy due to
CENP-E heterozygosity did not accelerate tumor initiation
or progression after treatment with this carcinogen.
The effect of aneuploidy on tumors initiated by the com-
plete absence of a tumor suppressor was also tested. Two
rounds of mating produced CENP-E+/ animals that were
deficient for the p19/ARF tumor-suppressor gene, as
well as p19/ARF/, CENP-E+/+ littermates. p19/ARF/
animals develop malignant cancers, predominantly sarco-
mas and lymphomas. Adding elevated rates of single-
chromosomal loss to tumors initiated by absence of the
p19/ARF tumor suppressor had a striking and unexpected
effect on survival. Elevated aneuploidy increased the
average tumor-free survival of these animals by a highly
significant 93 days (Figure 7D; p = 0.0079), with all but
one animal exhibiting a substantially longer tumor latency,
consistent with CENP-E heterozygosity abrogating the
limited growth in soft agar observed in late-passageCancer Cell 11, 25–36, January 2007 ª2007 Elsevier Inc. 31
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ARF/, CENP-E+/ animal developed a tumor with a very
short latency (62 days), consistent with the in vitro data
indicating that in rare instances aneuploidy can enhance
tumorigenicity caused by loss of the p19/ARF tumor sup-
pressor. p19/ARF/, CENP-E+/ animals did not exhibit
a shift in the tumor spectrum from lymphomas to solid tu-
mors. Moreover, we confirmed that tumors in p19/ARF/,
CENP-E+/ animals remained heterozygous for CENP-E
(Figure S4). Thus, aneuploidy from whole-chromosome
loss (or gain) can strongly delay in vivo tumorigenesis after
loss of the p19/ARF tumor-suppressor gene.
DISCUSSION
By reduction in a mitotic motor that is a component of
mitotic checkpoint signaling, we have demonstrated that
increased rates of single-chromosomal aneuploidy in the
absence of other observable defects can enhance trans-
formation in culture and spontaneous tumorigenesis
during aging, while diminishing tumor formation initiated
by loss of the p19/ARF tumor suppressor. These outcomes
provide a direct test of the 100-year-old hypothesis that
aneuploidy, a salient characteristic of solid tumors, drives
tumorigenesis. The unambiguous answer is that not only
can it do so (although perhaps not at the frequency that
some models have predicted [Duesberg et al., 2004]), but
Figure 5. CENP-E+/ Mice Develop Aneuploidy In Vivo
(A and B) Colon cells from CENP-E+/ animals have elevated levels
of aneuploidy. (A) Quantitation of aneuploidy (loss and gain) of the
Y chromosome and chromosome 2 in 19-month-old animals. *p <
0.05. (B) Interphase FISH image of a 6 mm tissue section from the colon
of a 19-month-old animal. DNA, blue; membrane dye FM4-64, red;
FISH paint probe to the entire Y chromosome, green.32 Cancer Cell 11, 25–36, January 2007 ª2007 Elsevier Inc.it can also inhibit tumorigenesis and the cellular context
is crucial. Both answers have important implications for
human tumors.
Figure 6. Aneuploidy Promotes Tumorigenesis
(A) Aged CENP-E+/ animals develop elevated levels of spontaneous
spleen (p = 0.0402) and lung (p = 0.0492) tumors.
(B–I) H&E-stained tissue sections. (B) Normal spleen showing circular
lymphoid follicles. (C–E) Lymphoma of the spleen showing effacement
of lymphoid follicles and replacement of splenic architecture with
a proliferation of neoplastic cells. (C) Box denotes region shown at
higher magnification in (D). (D) Box denotes region shown at higher
magnification in (E). Black arrow, neoplastic cell. White arrow, normal
cell. (E) Neoplastic cell (black arrow, same cell as in [D]) with a high
nucleus-to-cytoplasm ratio, an enlarged nucleus, and a prominent
nucleolus. Normal cells (white arrow, same cell as in [D]) have dense,
compact nuclei with very little cytoplasm. (F) Normal lung tissue exhib-
iting a lacy appearance. (G–I) Pulmonary adenoma of the lung. (G) Box
denotes region shown at higher magnification in (H). (H) Enlargement of
the border between the adenoma and the normal tissue, showing the
glandular appearance of the adenoma. Box denotes region shown at
higher magnification in (I). (I) Higher-magnification view of the delin-
eated border between the adenoma and the adjacent normal tissue.
Cancer Cell
Aneuploidy Both Promotes and Inhibits TumorsConsistent with human cancers, aneuploidy-induced
transformation is a slow process with a long latency,
requiring R30 passages in culture. Even then it is not
completely penetrant. Only a proportion of p19/ARF/,
CENP-E+/ cell lines acquired the ability to grow in soft
agar and to form tumors in nude mice, even after R40
passages in culture. This apparently required the complex
aneuploidy of the type routinely seen in solid human
tumors. In animals, tumorigenesis was a late event,
identified only in aged animals (19–21 months) and not in
all tissues.
Figure 7. Aneuploidy Inhibits Tumorigenesis
(A) Aged CENP-E+/ animals have a decreased rate of spontaneous
liver tumorigenesis.
(B) Liver tumors in CENP-E+/ animals are significantly smaller than
those found in CENP-E+/+ animals (p = 0.0037).
(C) CENP-E heterozygosity inhibits tumorigenesis in animals treated
with the carcinogen DMBA.
(D) Aneuploidy due to CENP-E heterozygosity delays tumorigenesis in
p19/ARF null mice.An additional insight from analysis of mice with mark-
edly enhanced levels of whole-chromosomal aneuploidy
is that CENP-E-deficient animals were remarkably normal
despite high levels of aneuploidy. In light of the widely held
presumption that the vast majority of cells in mammals
in vivo are diploid, it is remarkable that organ development
and function were relatively unimpaired, with little influ-
ence on normal growth, fertility, and life span (Figures
S5B–S5D). These findings also reinforce the pioneering
results of Chun and colleagues demonstrating that normal
mice contain significant levels of single-chromosomal an-
euploidy both in developing and adult neurons (Kaushal
et al., 2003; McConnell et al., 2004; Rehen et al., 2001;
Yang et al., 2003). Those authors have now extended
this work to show that these aneuploid neurons are func-
tional (Kingsbury et al., 2005). All of this challenges the as-
sumption of a requirement for strict diploidy in mammals.
A further unexpected finding is that whole-chromosomal
aneuploidy in vivo is characterized by a disproportionate
number of examples of loss relative to gain (Figures 5A–
5D). While it might be anticipated that chromosome losses
would be more detrimental to cellular survival than gains,
and hence would be underrepresented, the bias toward
chromosome loss was observed uniformly in every exper-
iment. Peripheral blood cells from animals from 2 to 20
months, as well as splenocytes from 8-month-old animals,
all displayed substantially higher proportions of cells with
fewer than a diploid complement of chromosomes than
those with greater than 2n. This bias has also been seen
in spontaneous aneuploidy in developing neurons (Kau-
shal et al., 2003; McConnell et al., 2004; Rehen et al.,
2001; Yang et al., 2003) as well as in cells heterozygous
for Mad2 (Michel et al., 2001) and in embryos expressing
a mutant version of the breast cancer gene BRCA1 (Shen
et al., 1998). Cells from mice heterozygous for BubR1
were also found to exhibit more losses than gains (Rao
et al., 2005), although this difference was not observed in
an independently created line (Baker et al., 2004). One
possibility for this tendency toward chromosome loss is
that lagging chromosomes in anaphase (produced by
incorrect initial attachment or maintenance of that attach-
ment) may be excluded from both daughter cells during
cytokinesis. Alternatively, it may be that gain of most chro-
mosomes results in increased levels of components that
trigger senescence or apoptotic responses, thereby
eliminating those cells from the cycling pool.
Aneuploidy has been argued to drive tumorigenesis (Li
et al., 1997), to promote tumor progression but not initia-
tion (Marx, 2002), and to be completely benign (Hahn
et al., 1999). Since, to our knowledge, aneuploidy has
never been proposed to inhibit tumorigenesis, this was
our most surprising finding. Previous experiments did
not uncover a role for aneuploidy in inhibiting tumorigene-
sis, even in animals with reduced levels of other proteins
(Mad2, Bub3, and BubR1) that, like CENP-E, participate
in the mitotic checkpoint. However, as detailed earlier,
unlike CENP-E, these proteins are expressed throughout
the cell cycle and have been implicated in apoptosis
(BubR1), transcriptional repression (Bub3), the DNACancer Cell 11, 25–36, January 2007 ª2007 Elsevier Inc. 33
Cancer Cell
Aneuploidy Both Promotes and Inhibits Tumorsreplication checkpoint (Mad2), and gross chromosomal
rearrangements (Mad2, Bub3, BubR1). Consistent with
this, Mad2 and BubR1 are expressed in differentiated
tissues, while CENP-E is found only in tissues with a
high proportion of dividing cells, such as testes and spleen
(Figure S1C). Additionally, Mad2 and Bub3 mRNAs are ex-
pressed in postmitotic cells of the brain, while CENP-E
mRNA is not (Allen Brain Atlas, http://www.brain-map.
org/). Therefore, reduction of Mad2, Bub3, or BubR1
would be anticipated to produce defects in addition to
simple increases in whole-chromosome aneuploidy that
might affect their tumor-suppressing potential.
How can whole-chromosomal aneuploidy drive tumor
suppression? Several factors probably converge to pro-
duce aneuploidy-mediated tumor inhibition. High levels
of chromosomal instability can prevent clonal expansion,
since cells that have acquired a rare transformative karyo-
type through multiple chromosome missegregations are
likely to lose that karyotype in the next round of cell
division. This situation is analogous to what has been
shown for chromosome missegregation in bacteria. While
low levels of instability provide a growth advantage, higher
levels of instability generate a so-called ‘‘mutational melt-
down’’ in which the population of highly aneuploid bacte-
ria loses viability (Lynch et al., 1993). Such sensitivity is
also analogous to genetic instability due to DNA damage.
Cells sustain low levels of DNA damage on a regular basis,
but this is normally countered by repair mechanisms.
Higher levels of DNA damage due to mutations in mis-
match repair enzymes result in viable cells but are associ-
ated with cancers, particularly hereditary nonpolyposis
colorectal cancer (HNPCC; Strate and Syngal, 2005). Che-
motherapeutic drugs (e.g., cisplatin) produce even higher
levels of DNA damage, provoking cellular death and tumor
regression. Our evidence now demonstrates that aneu-
ploidy behaves similarly: it both drives tumorigenesis,
as Boveri had initially proposed, and inhibits tumorigene-
sis, depending on the level of genomic damage that is
induced.
EXPERIMENTAL PROCEDURES
Cell Culture
Primary MEFs were generated from day E14.5 embryos as described
(http://medicine.wustl.edu/escore/htmldocs/protocol.htm). Primary
MEFs were grown in DMEM supplemented with 15% FBS, 0.1 mM
nonessential amino acids (Gibco), 1 mM 2-mercaptoethanol (Specialty
Media), 1 mM sodium pyruvate (Gibco), 2 mM glutamine, and 50 mg/ml
pen/strep in a 37C humidified incubator with 10% CO2 and 3% oxy-
gen. Low-oxygen conditions were used to extend the cycling time of
the primary cells (Parrinello et al., 2003). p19/ARF null cells were grown
in the same medium as primary MEFs in a 37C humidified incubator
with 7.5% CO2 in atmospheric oxygen. MEFs immortalized with SV40
large T were grown in DMEM supplemented with 10% FBS, 2 mM
glutamine, and 50 mg/ml pen/strep in a 37C humidified incubator
with 5% CO2 and atmospheric oxygen.
Chromosome Spreads/Metaphase Spreads
Chromosome spreads from lymphocytes from peripheral blood were
performed according to a Jackson Laboratory protocol (http://www.
jax.org/cyto/blood_preps.html). Briefly, 200 ml heparinized blood34 Cancer Cell 11, 25–36, January 2007 ª2007 Elsevier Inc.obtained from ocular bleeds was added to 950 ml RPMI containing
100 mg/ml gentamycin, 100 ml 112 mg/ml PHA, 100 ml 750 mg/ml LPS,
and 150 ml FBS. Cultures were incubated for 1.5 days at 37C before
150 ml of 50 mg/ml colchicine was added and the cultures were incu-
bated for an additional 4 hr. Cells were pelleted, gently resuspended
in 2–3 ml 75 mM KCl prewarmed to 37C, and incubated for 15 min
at 37C. Cells were pelleted and resuspended in a residual volume
of 250 ml, and then 3 ml fresh fix (3:1 methanol: acetic acid) was
added dropwise while the tubes were vortexed at low speed. Cells
were fixed at 4C overnight. Spreads were made as specified below.
To account for artifacts generated by the time in culture, aneuploidy
measurements were corrected for the amount of aneuploidy observed
in the youngest wild-type cells analyzed (10% in 2-month-old
animals).
Chromosome spreads from splenocytes were made by mincing
freshly harvested spleens with forceps, washing the cells with PBS,
resuspending in the same medium as above (including colchicine),
and incubating at 37C overnight. Cells were then harvested as above,
except they were incubated in room-temperature KCl for 30 min.
Cultured cells were grown to 80% confluence in 10 cm dishes.
Cells were arrested in mitosis with 100 ng/ml colcemid for 5 hr. Cells
(including the less-adherent mitotic cells in the medium) were pelleted
and resuspended in 3–5 ml 75 mM KCl for 10 min at room temperature.
Five drops of fresh fix were added before the cells were pelleted again.
Cells were resuspended in a residual volume of250 ml, and 3–5 ml fix
was added dropwise while the tube was vortexed at low speed. Cells
were fixed at 4C overnight.
Just before spreads were made, cells were washed twice with fresh
fix and resuspended in a small volume (100–250 ml). To prepare
spreads, 100 ml of cells was dropped onto a precleaned microscope
slide, which was dried slowly for 10 s in a fume hood and dried quickly
on an 80C hot plate for 30 s. DNA was visualized with DAPI.
SKY was performed as described previously (Bowen et al., 2005).
FISH
Paraffin sections (6 mm thick) were adhered to glass slides and
immersed in xylene for 2 3 20 min, and then for 1 min each in 100%,
85%, and 70% ethanol. Slides were washed in running tap water
and immersed in ddH2O before being pretreated with 0.2 N HCl for
20 min, washed in ddH2O for 3 min, incubated in 8% sodium thiocya-
nate for 30 min at 80C, washed in 23 SSC for 3 min, and digested in
0.5% pepsin in 0.2 N HCl for 1 hr at 37C. Slides were washed in
ddH2O for 1 min and in 23 SSC for 5 min and then dehydrated for 1
min each in 70%, 85%, and 100% ethanol. Slides were dried in
a 45C oven before being denatured in 70% formamide in 23 SSC
at 55C for 40 s. Denatured slides were placed in ice-cold 70% ethanol
and then room temperature 70%, 90%, and 100% ethanol for 3 min
each. Slides were then air dried. Star*FISH whole-chromosome paint
probes (Open Biosystems) were contemporaneously denatured by
incubation for 10 min at 80C and 30 min at 37C and then applied
to dried slides, before a coverslip was added and sealed with rubber
cement. Slides were incubated overnight at 37C in a humidified
chamber and then washed for 5 min 23 in 50% formamide in SSC,
23 in SSC, and 13 for 3 min in 43 SSC + 0.05% Tween 20, all at
45C. Cells were stained with DAPI and FM4-64 for 5 min before being
washed with PBS and mounted using Prolong. Image stacks were
acquired on a Nikon Eclipse TE 2000-E inverted spinning disk confocal
microscope and flattened into a maximal projection before being
scored. Both gains and losses of chromosomes were counted.
Transformation Assays
Focus formation assays were performed by plating cells in 6-well
plates and allowing them to grow to confluence. Confluent cells
were washed with PBS, fixed with methanol for 30 min, washed with
PBS, and stained with 0.05% crystal violet for 30 min at room temper-
ature before being washed with PBS and allowed to dry.
Soft agar assays were performed by plating 1 ml (2 ml for primary
MEFs) of a 1:1 mix of 23 media and 1.2% agar per well of a 12-well
Cancer Cell
Aneuploidy Both Promotes and Inhibits Tumorsplate. Cells (2.5 3 105) in a 1:1 mix of 23 media and 0.6% agar were
layered on top of the bottom agar after it solidified.
Nude mice injection experiments were performed by subcutane-
ously injecting 5 3 106 cells in PBS into 4- to 5-week-old nude mice.
All experiments were performed in accordance with standards estab-
lished by the Institutional Animal Care and Use Committee at UCSD.
Tumor Analysis and Histology
Aged animals were sacrificed by cervical dislocation following anes-
thetization with isofluorine. Necropsies were performed, and tissues
as well as tumors observed by gross inspection were fixed in 10%
formalin overnight at room temperature and then stored at 4C before
being embedded in paraffin. Hematoxylin-and-eosin-stained, 5 mm
thick sections were prepared by the UCSD histology core and
analyzed by Dr. Nissi Varki.
Supplemental Data
The Supplemental Data include six supplemental figures, one supple-
mental table, and one supplemental movie and can be found with
this article online at http://www.cancercell.org/cgi/content/full/11/1/
25/DC1/.
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